BIBB Stock Overview
BiBBInstruments AB, a medtech company, offers electric endoscopic biopsy instruments for cancer diagnosis.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BiBBInstruments AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr4.89 |
| 52 Week High | kr5.00 |
| 52 Week Low | kr2.20 |
| Beta | 1.02 |
| 1 Month Change | 3.60% |
| 3 Month Change | 61.92% |
| 1 Year Change | 47.29% |
| 3 Year Change | -38.88% |
| 5 Year Change | n/a |
| Change since IPO | -45.67% |
Recent News & Updates
Shareholder Returns
| BIBB | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0.2% | -0.4% | -0.9% |
| 1Y | 47.3% | -9.6% | 8.2% |
Return vs Industry: BIBB exceeded the Swedish Medical Equipment industry which returned -9.6% over the past year.
Return vs Market: BIBB exceeded the Swedish Market which returned 8.2% over the past year.
Price Volatility
| BIBB volatility | |
|---|---|
| BIBB Average Weekly Movement | 11.3% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 13.1% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: BIBB's share price has been volatile over the past 3 months.
Volatility Over Time: BIBB's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 3 | Fredrik Lindblad | www.bibbinstruments.se |
BiBBInstruments AB, a medtech company, offers electric endoscopic biopsy instruments for cancer diagnosis. It is developing EndoDrill, an electric endoscopic biopsy instrument for endoscopic use. The company was incorporated in 2013 and is based in Lund, Sweden.
BiBBInstruments AB Fundamentals Summary
| BIBB fundamental statistics | |
|---|---|
| Market cap | kr129.73m |
| Earnings (TTM) | -kr10.97m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-11.8x
P/E RatioIs BIBB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIBB income statement (TTM) | |
|---|---|
| Revenue | kr0 |
| Cost of Revenue | kr0 |
| Gross Profit | kr0 |
| Other Expenses | kr10.97m |
| Earnings | -kr10.97m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 03, 2024
| Earnings per share (EPS) | -0.41 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did BIBB perform over the long term?
See historical performance and comparison